विवरण
Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses.
Figure 14
ChartSource Paper
Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled …Cite This Figure
![Figure 14: Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses.]() > Source: Erin D Lewis et al. "Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in A." *Nutrients*, 2020. PMID: [32326347](https://pubmed.ncbi.nlm.nih.gov/32326347/)
<figure> <img src="" alt="Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses." /> <figcaption>Figure 14. Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses.<br> Source: Erin D Lewis et al. "Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in A." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32326347/">32326347</a></figcaption> </figure>